Complement inhibition enables renal allograft accommodation and long-term engraftment in presensitized nonhuman primates.
about
Computational Biology: Modeling Chronic Renal Allograft InjuryThe Complement System and Antibody-Mediated Transplant RejectionComplement in disease: a defence system turning offensiveNew milestones ahead in complement-targeted therapy.Current progress in ABO-incompatible kidney transplantationRational clinical trial design for antibody mediated renal allograft injury.Applying complement therapeutics to rare diseases.Progress and Trends in Complement TherapeuticsComplement in immune and inflammatory disorders: pathophysiological mechanismsComplement in immune and inflammatory disorders: therapeutic interventions.Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications.The role of complement in antibody-mediated rejection in kidney transplantation.An update on ABO-incompatible kidney transplantation.Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment.Strategies to overcome the ABO barrier in kidney transplantation.From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage.Acute Antibody-Mediated Rejection in Renal Transplantation: Current Clinical Management.Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cells.Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation.Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumab.Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.Modulation of Innate Immune Cells to Create Transplant Tolerance
P2860
Q26797336-BDC39649-70E4-4E41-8771-66F48A4F2361Q28087773-743C0855-65C6-4043-978D-BBF3C5545FAAQ33432423-EB47B4FA-87F0-456E-AC74-AE4DEB28C3E9Q33602320-41D020A7-90ED-4FFC-89C0-934D4981C844Q36171175-F0526CC2-1B36-4765-93B0-3E0CCA5F5252Q36173541-678D0F6B-8867-4844-8587-22DFEE5D87EDQ36315497-BB92ED07-06B7-4D46-994B-6314A7B6AD54Q36479278-7EB00740-82BC-420F-8189-A76CDB3BE589Q36756850-0D740A7E-FEB7-481C-B32E-5FFC70217CC6Q36756854-E99B2FB4-D0D2-4B09-9DF3-BD6C61E765ACQ37642331-4DFA2DFA-215A-47A5-8D62-2160E50B2144Q38048605-633864DD-1C86-4D6B-9649-704B07581C99Q38267202-0145ABC5-7568-4EB7-8CD0-38740A6EA290Q38541350-12246CA2-D0A6-4C07-858F-0C5AA2095EA4Q38577657-C8C636E9-EDA3-4563-9A29-97014E78BE61Q38879877-7D5051E1-2A71-4381-951B-34D32991267BQ41118002-41080A8A-8E40-43EB-8961-ED4F31998F62Q41849097-81718A65-FA7D-4BD3-8733-73F4854560CFQ47588581-958011B1-FDB3-4F95-9E48-AF6FA5EBC410Q50042914-CDC1CDF6-B99F-4C21-A49D-A33C6E6A43B0Q51333222-30024C39-640E-4D9D-9980-BC65E29300B7Q54967868-6C409F30-58C5-4E48-87F6-74D7AA0B1BA6Q57202180-33D1A3FD-5D50-4BBD-A318-D7F4015866DE
P2860
Complement inhibition enables renal allograft accommodation and long-term engraftment in presensitized nonhuman primates.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Complement inhibition enables ...... esensitized nonhuman primates.
@en
Complement inhibition enables ...... esensitized nonhuman primates.
@nl
type
label
Complement inhibition enables ...... esensitized nonhuman primates.
@en
Complement inhibition enables ...... esensitized nonhuman primates.
@nl
prefLabel
Complement inhibition enables ...... esensitized nonhuman primates.
@en
Complement inhibition enables ...... esensitized nonhuman primates.
@nl
P2093
P2860
P1476
Complement inhibition enables ...... esensitized nonhuman primates.
@en
P2093
S Chen Shi
S Chen Song
P2860
P304
P356
10.1111/J.1600-6143.2011.03646.X
P407
P577
2011-08-10T00:00:00Z